Oral antidiabetes drugs

Oral antidiabetes drugs are of two kinds: sulphon-amide derivatives (sulphonylureas) and guanidine derivatives (biguanides). They are used by 30% of all diabetics. Unlike insulin they are not essential for life.

Following the observation in 1918 that guanidine had hypoglycaemic effect, guanides were tried in diabetes in 1926, but were abandoned a few years later for fear of hepatic toxicity.

In 1930 it was noted that sulphonamides could cause hypoglycaemia, and in 1942 severe hypoglycaemia was found in patients with typhoid fever during a therapeutic trial of sulphonamide. In the 1950s a similar observation was made during a chemotherapeutic trial in urinary infections. This was followed up and effective drugs soon resulted. The first sulphonylureas were introduced into clinical practice in 1954.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment